PSCA and prostate cancer: The objective of the present study was to detect prostate stem cell antigen (PSCA) expression correlated with tumor grade and stage in human prostate cancer by QDs-based immunolabeling and conventional immunohistochemistry (IHC), and evaluate the sensitivity and stability of QDs-based immunolabeling in comparison with IHC.